Efficacy and Safety Assessment of T4032 Versus Lumigan® in Ocular Hypertensive or Glaucomatous Patients
NCT03825380 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 485
Last updated 2023-11-21
Summary
The purpose of this study is to assess the efficacy and safety of T4032 versus Lumigan.
Conditions
Interventions
- DRUG
-
Bimatoprost
Eyedrops
- DRUG
-
Lumigan®
Eyedrops
Sponsors & Collaborators
-
Laboratoires Thea
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-11-23
- Primary Completion
- 2021-02-03
- Completion
- 2021-02-24
Countries
- Estonia
Study Locations
More Related Trials
-
Efficacy and Safety Assessment of T4030 Eye Drops Versus Ganfort® UD in Ocular Hypertensive or Glaucomatous Patients.
NCT04898387 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction
NCT01547598 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT04285580 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®
NCT01664039 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
NCT01568008 ·Status: COMPLETED
-
Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
NCT01628588 ·Status: COMPLETED
-
A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons
NCT01853085 ·Status: COMPLETED
-
Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension
NCT01489670 ·Status: COMPLETED
-
Comparing Safety and Efficacy of Combigan® and Lumigan® With Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated With Xalatan®
NCT01170884 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
NCT01632423 ·Status: COMPLETED
-
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
NCT05401357 ·Status: RECRUITING ·Phase: PHASE3
-
Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution
NCT01001195 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US
NCT00847483 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
NCT01589510 ·Status: COMPLETED
-
Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension
NCT03850782 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
NCT01099774 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
NCT01830140 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparative Study of SPARC's SDP-133 Once Daily and Lumigan in Subjects With Open Angle Glaucoma or Ocular Hypertension
NCT03927443 ·Status: WITHDRAWN ·Phase: PHASE3
-
Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular Hypertension
NCT02507687 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Different Drugs on Ocular Surface Disease in Glaucoma Patients: a Prospective Randomised Study
NCT04896125 ·Status: UNKNOWN
-
Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension
NCT00348023 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Bimatoprost 0.01% in the Clinical Setting
NCT01814761 ·Status: COMPLETED
-
The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye
NCT00705757 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension
NCT01863953 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
NCT00300443 ·Status: COMPLETED ·Phase: PHASE2/PHASE3